Injectable insulin treatment is the most used to treat type 1 diabetes mellitus (DM1) and, in many cases, type 2 diabetes mellitus (DM2); however, factors such as pain of application and inconvenience associated with injections are among those contributing to low adherence to this treatment. The gene discussed is INS; the disease is diabetes mellitus.